Feedback / Questions
gersizangitide (AXT107) - Asclepix
https://www.globenewswire.com/news-release/2024/05/06/2875637/0/en/AsclepiX-Therapeutics-Completes-Enrollment-in-DISCOVER-Trial-for-Neovascular-Age-Related-Macular-Degeneration-nAMD.html
May 6, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next